Wells Fargo’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $14.4K | Buy |
|
|||||
|
2022
Q4 | $353 | Sell |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $397K | Sell |
|
|||||
|
2021
Q4 | $564K | Sell |
|
|||||
|
2021
Q3 | $1.42M | Buy |
|
|||||
|
2021
Q2 | $985K | Sell |
|
|||||
|
2021
Q1 | $2.5M | Buy |
|
|||||
|
2020
Q4 | $788K | Buy |
|
|||||
|
2020
Q3 | $753K | Buy |
|
|||||
|
2020
Q2 | $576K | Buy |
|
|||||
|
2020
Q1 | $351K | Buy |
|
|||||
|
2019
Q4 | $490K | Buy |
|
|||||
|
2019
Q3 | $150K | Buy |
|
|||||
|
2019
Q2 | $191K | Sell |
|
|||||
|
2019
Q1 | $244K | Sell |
|
|||||
|
2018
Q4 | $158K | Buy |
|
|||||
|
2018
Q3 | $251K | Sell |
|
|||||
|
2018
Q2 | $297K | Buy |
|
|||||
|
2018
Q1 | $840K | Sell |
|
|||||
|
2017
Q4 | $534K | Buy |
|
|||||
|
2017
Q3 | $324K | Sell |
|
|||||
|
2017
Q2 | $294K | Buy |
|
|||||
|
2017
Q1 | $80K | Buy |
|